Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Nautilus Biotechnology total assets
Total assets on the balance sheet at the end of each period.
Nautilus Biotechnology's total assets was $148.92M at Sep 30, 2026. For fiscal 2025 it was $191.11M, down 21.3% from the year before. The highest annual figure on record is $398.45M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $191.11M | -21.3% |
| FY2024 | Dec 31, 2024 | $242.74M | -20.6% |
| FY2023 | Dec 31, 2023 | $305.57M | -12.7% |
| FY2022 | Dec 31, 2022 | $350.05M | -12.1% |
| FY2021 | Dec 31, 2021 | $398.45M | +368.7% |
| FY2020 | Dec 31, 2020 | $85.01M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $148.92M | -25.9% |
| Q2 FY2026 | Jun 30, 2026 | $163.58M | -23.3% |
| Q1 FY2026 | Mar 31, 2026 | $177.78M | -21.9% |
| Q4 FY2025 | Dec 31, 2025 | $191.11M | -21.3% |
| Q3 FY2025 | Sep 30, 2025 | $200.92M | -22.6% |
| Q2 FY2025 | Jun 30, 2025 | $213.19M | -21.8% |
| Q1 FY2025 | Mar 31, 2025 | $227.69M | -21.1% |
| Q4 FY2024 | Dec 31, 2024 | $242.74M | -20.6% |
| Q3 FY2024 | Sep 30, 2024 | $259.70M | -18.4% |
| Q2 FY2024 | Jun 30, 2024 | $272.75M | -17.5% |
| Q1 FY2024 | Mar 31, 2024 | $288.65M | -16.5% |
| Q4 FY2023 | Dec 31, 2023 | $305.57M | -12.7% |
| Q3 FY2023 | Sep 30, 2023 | $318.34M | -11.4% |
| Q2 FY2023 | Jun 30, 2023 | $330.77M | -11.0% |
| Q1 FY2023 | Mar 31, 2023 | $345.88M | -10.1% |
| Q4 FY2022 | Dec 31, 2022 | $350.05M | -12.1% |
| Q3 FY2022 | Sep 30, 2022 | $359.31M | -6.8% |
| Q2 FY2022 | Jun 30, 2022 | $371.71M | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | $384.67M | +155.6% |
| Q4 FY2021 | Dec 31, 2021 | $398.45M | +368.7% |
| Q3 FY2021 | Sep 30, 2021 | $385.35M | +155.3% |
| Q2 FY2021 | Jun 30, 2021 | $393.28M | +185998.7% |
| Q1 FY2021 | Mar 31, 2021 | $150.50M | – |
| Q4 FY2020 | Dec 31, 2020 | $85.01M | – |
| Q3 FY2020 | Sep 30, 2020 | $150.95M | – |
| Q2 FY2020 | Jun 30, 2020 | $211.33K | – |
See a number that looks wrong?